drugset / Trial / NCT01471886

Comparison Of Ketorolac Tromethamine Versus Naproxen For Moderate to Severe Back Pain Treatment

NCT01471886

Phase 3 Completed 83 enrolled EMS
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the non-inferiority of the clinical efficacy of two different drugs in the treatment of patients diagnosed with moderate to severe back pain.

Timeline

Start
2013-03
Primary completion
2013-10
Completion
2013-11-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Tromethamine Small molecule 10 mg Subcutaneous
Comparator Naproxen Small molecule 250 mg Oral

Indications

No indication recorded.